|
|
Volumn 95, Issue 22, 1998, Pages 12750-12752
|
|
RNA virus vectors: Where are we and where do we need to go?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BETA GALACTOSIDASE;
CANCER VACCINE;
PUROMYCIN;
RECOMBINANT DNA;
VACCINE;
VIRUS VECTOR;
CYTOPATHOGENIC EFFECT;
DNA TRANSFECTION;
DNA VIRUS;
ELECTROPORATION;
GENE EXPRESSION;
GENE THERAPY;
GENETIC ENGINEERING;
IMMUNE RESPONSE;
MOLECULAR CLONING;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REPLICON;
REPORTER GENE;
RNA VIRUS;
SIMIAN VIRUS 40;
SINDBIS VIRUS;
VACCINE PRODUCTION;
VIRUS GENE;
VIRUS MUTANT;
VIRUS REPLICATION;
CELL LINE;
GENETIC VECTORS;
HUMANS;
REPLICON;
RNA VIRUSES;
SINDBIS VIRUS;
TRANSFECTION;
DNA VIRUSES;
RNA VIRUSES;
SIMIAE;
SIMIAN VIRUS;
SIMIAN VIRUS 40;
SINDBIS VIRUS;
|
|
EID: 0032573071
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.95.22.12750 Document Type: Note |
|
Times cited : (20)
|
|
References (39)
|
